What is ibogaine? Trump admin fast-tracks psychoactive drug for approval

The Trump administration is fast-tracking its approval, but what is ibogaine?

Traferox Technologies Receives FDA Premarket Approval for the TorEx Lung Perfusion System

Traferox Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval ...

FDA drug approval affects healthcare around the world, but political shortcuts could hurt the agency’s international reputation

At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with ...

Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD

Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically ...

An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition

The group met on July 24 to vote on whether compounding pharmacies could legally dispense certain peptides.

Celcuity: 'Buy' REVTORPYK FDA Approval First And sNDA Label Expansion Q3 2026

Celcuity wins FDA approval for REVTORPYK in HR+/HER2- breast cancer; outlook tempered by phase 3 data, competition & launch ...
Food Processing

New Details Emerge on FDA's GRAS Rulemaking

Although Secretary Kennedy promised it months ago, a new rule for the Generally Recognized as Safe process is scheduled to be ...

DBV Technologies: Viaskin's FDA Path Still Leaves Room For More Upside

DBV Technologies buy call: 24% upside to $17 as Viaskin nears a Q3 2026 BLA. Click here to read more about DBVT.

FDA advisers vote against sleep peptide as they debate safety and health claims

A group of experts, some of whom work in the peptide industry, said the Food and Drug Administration should allow six ...
FiercePharma

With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma

The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard of care for patients with breast cancer. The regulator is allowing ...